Skip to main content
Equibles

Blackstone Inc.

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1393818 NEW YORK, NY
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,212,584
-$981,880 QoQ
Shares Held
904,959
0.0% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. LXEO ranks #14 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AUTL
Autolus Therapeutics plc
 20,485,611 $32,776,977
2 DFTX
Definium Therapeutics, Inc.
 561,612 $26,418,228
3 DMRA
Damora Therapeutics, Inc.
 1,002,971 $26,087,275
4 ARTV
Artiva Biotherapeutics, Inc.
 2,403,437 $23,313,338
5 ORKA
Oruka Therapeutics, Inc.
 237,108 $22,565,568
6 ALXO
Alx Oncology Holdings Inc
 6,593,543 $13,648,634
7 XFOR
X4 Pharmaceuticals, Inc
 2,681,922 $12,524,575
8 IKT
Inhibikase Therapeutics, Inc.
 5,938,276 $12,054,700

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,212,584 904,959
2026-03-31 $5,194,464 904,959
2025-12-31 $8,986,242 904,959
2025-09-30 $7,469,482 1,124,922
2025-06-30 $4,522,186 1,124,922
2025-03-31 $4,020,400 1,158,617
2024-12-31 $7,623,699 1,158,617
2024-09-30 $10,473,897 1,158,617
2024-06-30 $12,924,342 805,757
2024-03-31 $10,915,004 696,110
2023-12-31 $9,341,796 696,110